Abstract
Clostridium difficile infection (CDI) is an important healthcare-associated disease worldwide, mainly occurring after antimicrobial therapy. Antibiotics administered to treat a number of infections can promote C. difficile colonization of the gastrointestinal tract and, thus, CDI. A rise in multidrug resistant clinical isolates to multiple antibiotics and their reduced susceptibility to the most commonly used antibiotic molecules have made the treatment of CDI more complicated, allowing the persistence of C. difficile in the intestinal environment.
Gut colonization and biofilm formation have been suggested to contribute to the pathogenesis and persistence of C. difficile. In fact, biofilm growth is considered as a serious threat because of the related increase in bacterial resistance that makes antibiotic therapy often ineffective. However, although the involvement of the C. difficile biofilm in the pathogenesis and recurrence of CDI is attracting more and more interest, the mechanisms underlying biofilm formation of C. difficile as well as the role of biofilm in CDI have not been extensively described.
Findings on C. difficile biofilm, possible implications in CDI pathogenesis and treatment, efficacy of currently available antibiotics in treating biofilm-forming C. difficile strains, and some antimicrobial alternatives under investigation will be discussed here.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
AbdelKhalek A, Ashby CR, Patel BA et al (2016) In vitro antibacterial activity of rhodanine derivatives against pathogenic clinical isolates. PLoS One 11(10):e0164227
Aldridge P, Paul R, Goymer P et al (2003) Role of the GGDEF regulator PleD in polar development of Caulobacter crescentus. Mol Microbiol 47:1695–1708
Al-Hinai MA, Jones SW, Papoutsakis ET (2015) The Clostridium sporulation programs: diversity and preservation of endospore differentiation. Microbiol Mol Biol Rev 79:19–37
Alves P, Castro J, Sousa C et al (2014) Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. J Infect Dis 210:593–596
Azeredo J, Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9:261–266
Azriel S, Goren A, Rahav G et al (2015) The stringent response regulator DksA is required for Salmonella enteric Serovar Typhimurium growth in minimal medium, motility, biofilm formation, and intestinal colonization. Infect Immun 84:375–384
Badet C, Quero F (2011) The in vitro effect of manuka honeys on growth and adherence of oral bacteria. Anaerobe 17:19–22
Barbut F, Richard A, Hamadi K et al (2000) Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol 38:2386–2388
Biazzo M, Cioncada R, Fiaschi L et al (2013) Diversity of cwp loci in clinical isolates of Clostridium difficile. J Med Microbiol 62:1444–1452
Bordeleau E, Fortier LC, Malouin F et al (2011) c-di-GMP turn-over in Clostridium difficile is controlled by a plethora of diguanylatecyclases and phosphodiesterases. PLoS Genet 7:e1002039
Bordeleau E, Purcell EB, Lafontaine DA et al (2015) Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile. J Bacteriol 197:819–832
Borriello SP (1979) Clostridium difficile and its toxin in the gastrointestinal tract in health and disease. Res Clin Forums 1:33–35
Borriello SP, Welch AR, Barclay FE et al (1988) Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. J Med Microbiol 25:191–19629
Boudry P, Gracia C, Monot M et al (2014) Pleiotropic role of the RNA chaperone protein Hfq in the human pathogen Clostridium difficile. J Bacteriol 196:3234–3248
Bouillaut L, Dubois T, Sonenshein AL et al (2015) Integration of metabolism and virulence in Clostridium difficile. Res Microbiol 166:375–383
Buckley AM, Spencer J, Candlish D et al (2011) Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J Med Microbiol 60:1174–1180
Butala M, Žgur-Bertok D, Busby SJW (2009) The bacterial LexA transcriptional repressor. Cell Mol Life Sci 66(1):82–93
Cairns LS, Marlow VL, Bissett E et al (2013) A mechanical signal transmitted by the flagellum controls signalling in Bacillus subtilis. Mol Microbiol 90:6–21
Cairns LS, Hobley L, Stanley-Wall NR (2014) Biofilm formation by Bacillus subtilis: new insights into regulatory strategies and assembly mechanisms. Mol Microbiol 93:587–598
Carter GP, Purdy D, Williams P et al (2005) Quorum sensing in Clostridium difficile: analysis of a luxS-type signalling system. J Med Microbiol 54:119–127
Carter GP, Rood JI, Lyras D (2012) The role of toxin A and toxin B in the virulence of Clostridium difficile. Trends Microbiol 20:21–29
Cerquetti M, Molinari A, Sebastianelli A et al (2000) Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog 28:363–372
Chao Y, Vogel J (2010) The role of Hfq in bacterial pathogens. Curr Opin Microbiol 13:24–33
Chilton CH, Crowther GS, Freeman J et al (2014) Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure. J Antimicrob Chemother 69:451–462
Ciofu O, Rojo-Molinero E, Macià MD et al (2017) Antibiotic treatment of biofilm infections. APMIS 125:304–319
Crowther GS, Chilton CH, Todhunter SL et al (2014a) Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model. J Antimicrob Chemother 69:2137–2147
Crowther GS, Chilton CH, Todhunter SL et al (2014b) Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota. PLo SONE 9:e88396
Cummings JH, Antoine JM, Azpiroz F et al (2004) PASSCLAIM: gut health and immunity. Eur J Nutr 43:II118–II173
Dapa T, Unnikrishnan M (2013) Biofilm formation by Clostridium difficile. Gut Microbes 4:397–402
Ðapa T, Leuzzi R, Baban ST et al (2013) Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol 195:545–555
Dawson LF, Valiente E, Faulds-Pain A et al (2012) Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS One 7:e50527
de la Riva L, Willing SE, Tate EW et al (2011) Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile. J Bacteriol 193:3276–3285
De Sordi L, Butt MA, Pye H et al (2015) Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficile. PLoS One 10:e0135039
Dineen SS, McBride SM, Sonenshein AL (2010) Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol 192:5350–5362
Donelli G (2006) Vascular catheter-related infection and sepsis. Surg Infect 7:S25–S27
Donelli G, Vuotto C, Cardines R et al (2012) Biofilm-growing intestinal anaerobic bacteria. FEMS Immunol Med Microbiol 65:318–325
Dupont HL (2013) Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol 11:1216–1223
Edwards AN, Nawrocki KL, McBride SM (2014) Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile. Infect Immun 82:4276–4291
Fagan RP, Fairweather NF (2014) Biogenesis and functions of bacterial S-layers. Nat Rev Microbiol 12:211–222
Faulds-Pain A, Twine SM, Vinogradov E et al (2014) The post-translational modification of the Clostridium difficile flagellin affects motility, cell surface properties and virulence. Mol Microbiol 94:272–289
Flemming HC, Wingender J (2010) The biofilm matrix. Nat Rev Microbiol 8:623–633
Furukawa K, Gu H, Sudarsan N et al (2012) Identification of ligand analogues that control c-di-GMP riboswitches. ACS ChemBiol 7:1436–1443
Ganeshapillai J, Vinogradov E, Rousseau J et al (2008) Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units. Carbohydr Res 343:703e10
Ghosh S, Zhang P, Li YQ et al (2009) Superdormant spores of Bacillus species have elevated wet-heat resistance and temperature requirements for heat activation. J Bacteriol 191:5584–5591
Gil F, Paredes-Sabja D (2016) Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections. Future Microbiol 11:1179–1189
Gil F, Pizarro-Guajardo M, Álvarez R (2015) Clostridium difficile recurrent infection: possible implication of TA systems. Future Microbiol 10:1649–1657
Goldberg J (2002) Biofilms and antibiotic resistance: a genetic linkage. Trends Microbiol 10:264
Goulding D, Thompson H, Emerson J et al (2009) Distinctive profiles of infection and pathology in hamsters infected with Clostridium difficile strains 630 and B1. Infect Immun 77:5478–5485
Hall-Stoodley L, StoodleyP (2009) Evolving concepts in biofilm infections. Cell Microbiol 11:1034–1043
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108
Hammond EN, Donkor ES, Brown CA (2014) Biofilm formation of Clostridium difficile and susceptibility to Manuka honey. BMC Complement Altern Med 14:329
Hashem AA, Abd El Fadeal NM et al (2017) In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. J Med Microbiol 66:744–752
Heydorn A, Ersboll B, Hentzer M et al (2000) Experimental reproducibility in flow-chamber biofilms. Microbiology 146:2409–2415
Hoiby N, Bjarnsholt T, Givskov M et al (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35:322–332
Jimi S, Miyazaki M, Takata T et al (2017) Increased drug resistance of meticillin-resistant Staphylococcus aureus biofilms formed on a mouse dermal chip model. J Med Microbiol 66:542–550
Kirby JM, Ahern H, Roberts AK et al (2009) Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J Biol Chem 284:34666–34673
Klausen M, Aaes-Jørgensen A, Molin S et al (2003) Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol Microbiol 50:61–68
Koch B, Worm J, Jensen LE et al (2001) Carbon limitation induces s-dependent gene expression in Pseudomonas fluorescens in soil. Appl Environ Microbiol 67:3363–3370
Kulasakara H, Lee V, Brencic A et al (2006) Analysis of Pseudomonas aeruginosa diguanylatecyclases and phosphodiesterases reveals a role for bis-(3′-5′)-cyclic-GMP in virulence. Proc Natl Acad Sci 103:2839–2844
Lawley TD, Clare S, Walker AW et al (2009) Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 77:3661–3669
Lee ASY, Song KP (2005) LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem Biophys Res Commun 335:659–666
Li YH, Tian X (2012) Quorum sensing and bacterial social interactions in biofilms. Sensors (Basel) 12:2519–2538
Lindsay D, von Holy A (2006) Bacterial biofilms within the clinical setting: what healthcare professionals should know. J Hosp Infect 64:313–325
Lipovsek S, Leitinger G, Rupnik M (2013) Ultrastructure of Clostridium difficile colonies. Anaerobe 24:66e70
Liu W, Røder HL, Madsen JS et al (2016) Interspecific bacterial interactions are reflected in multispecies biofilm spatial organization. Front Microbiol 7:1366
Lyra A, Forssten S, Rolny P et al (2012) Comparison of bacterial quantities in left and right colon biopsies and faeces. World J Gastroenterol 18:4404–4411
Macfarlane S, Dillon JF (2007) Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 102:1187–1196
Macfarlane S, Macfarlane GT (2006) Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut. Appl Environ Microbiol 72:6204–6211
Macfarlane GT, Macfarlane S, Gibson GR (1998) Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35:180–187
Macfarlane S, Bahrami B, Macfarlane GT (2011) Mucosal biofilm communities in the human intestinal tract. Adv Appl Microbiol 75:111–143
Machado D, Castro J, Palmeira-de-Oliveira A et al (2015) Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Front Microbiol 6:152
Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39
Maldarelli GA, De Masi L, von Rosenvinge EC et al (2014) Identification, immunogenicity and cross-reactivity of Type IV pilin and pilin-like proteins from Clostridium difficile. Pathog Dis 71:302–314
Maldarelli GA, Piepenbrink KH, Scott AJ et al (2016) Type IV pili promote early biofilm formation by Clostridium difficile. Pathog Dis 74:ftw061
Mathur H, Rea MC, Cotter PD et al (2016) The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells. Gut Pathog 8:20
Meeker DG, Beenken KE, Mills WB et al (2016) Evaluation of antibiotics active against methicillin-resistant Staphylococcus aureus based on activity in an established biofilm. Antimicrob Agents Chemother 60:5688–5694
Melville S, Craig L (2013) Type IV pili in Gram-Positive bacteria. Microbiol Mol Biol Rev 77:323–341
Mhatre E, Monterrosa RG, Kovács ÁT (2014) From environmental signals to regulators: modulation of biofilm development in Gram-positive bacteria. J Basic Microbiol 54:616–632
Nale JY, Chutia M, Carr P et al (2016) ‘Get in Early’; biofilm and wax moth (Galleria mellonella) models reveal new insights into the therapeutic potential of Clostridium difficile bacteriophages. Front Microbiol 7:1383
Nassif X, Beretti JL, Lowy J et al (1994) Roles of pilin and PilC in adhesion of Neisseria meningitidis to human epithelial and endothelial cells. Proc Natl Acad Sci U S A 91:3769–3773
Ng KM, Ferreyra JA, Higginbottom SK et al (2013) Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96–99
Normington C, Chilton C, Buckley A, et al (2017) Influence of gut microflora on C. difficile biofilm formation. In: Microbiology society annual conference, p P418
Ofosu A (2016) Clostridium difficile infection: a review of current and emerging therapies. Ann Gastroenterol 29:147–154
Owrangi B, Masters N, Vollmerhausen TL et al (2017) Comparison between virulence characteristics of dominant and non-dominant Escherichia coli strains of the gut and their interaction with Caco-2 cells. Microb Pathog 105:171–176
Ozturk B, Gunay N, Ertugrul BM et al (2016) Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model. Can J Microbiol 62:735–743
Pantaléon V, Bouttier S, Soavelomandroso AP et al (2014) Biofilms of Clostridium species. Anaerobe 30:193–198
Pantaléon V, Soavelomandroso AP, Bouttier S et al (2015) The Clostridium difficile protease Cwp84 modulates both biofilm formation and cell- surface properties. PLoS One 10:1–20
Peng JS, Tsai WC, Chou CC (2002) Inactivation and removal of Bacillus cereus by sanitizer and detergent. Int J Food Microbiol 77:11–18
Peng Z, Jin D, Kim HB et al (2017) Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing. J Clin Microbiol 55:1998–2008
Percival SL, Suleman L, Francolini I et al (2014) The effectiveness of photodynamic therapy on planktonic cells and biofilms and its role in wound healing. Future Microbiol 9:1083–1094
Percival SL, Suleman L, Vuotto C et al (2015) Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol 64:323–334
Pettit LJ, Browne HP, Yu L et al (2014) Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics 15:160
Piepenbrink KH, Maldarelli GA, de la Peña CF et al (2014) Structure of Clostridium difficile PilJ exhibits unprecedented divergence from known Type IV pilins. J Biol Chem 289:4334–4345
Piepenbrink KH, Maldarelli GA, Martinez de la Peña CF et al (2015) Structural and evolutionary analyses show unique stabilization strategies in the Type IV pili of Clostridium difficile. Structure 23:385–396
Piotrowski M, Karpiński P, Pituch H, van Belkum A, Obuch-Woszczatyński P (2017) Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-017-2980-1
Pizarro-Guajardo M, Calderón-Romero P, Castro-Córdova P et al (2016a) Ultrastructural variability of the exosporium layer of Clostridium difficile spores. Appl Environ Microbiol 82:2202–2209
Pizarro-Guajardo M, Calderón-Romero P, Paredes-Sabja D (2016b) Ultrastructure variability of the exosporium layer of Clostridium difficile spores from sporulating cultures and biofilms. Appl Environ Microbiol 82:5892–5898
Plummer S, Weaver MA, Harris JC et al (2004) Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C .difficile. Int Microbiol 7:59–62
Purcell EB, McKee RW, McBride SM et al (2012) Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile. J Bacteriol 194:3307–3316
Purcell EB, McKee RW, Bordeleau E et al (2016) Regulation of Type IV pili contributes to surface behaviours of historical and epidemic strains of Clostridium difficile. J Bacteriol 198:565–577
Purcell EB, McKee RW, Courson DS et al (2017) A nutrient-regulated cyclic diguanylate phosphodiesterase controls Clostridium difficile biofilm and toxin production during stationary phase. Infect Immun 85:IAI.00347–IAI.00317
Raponi G, Visconti V, Brunetti G et al (2014) Clostridium difficile infection and Candida colonization of the gut: is there a correlation? Clin Infect Dis 59:1648–1649
Ribeiro SM, Felício MR, Boas EV et al (2016) New frontiers for anti-biofilm drug development. Pharmacol Ther 160:133–144
Römling U, Amikam D (2006) Cyclic di-GMP as a second messenger. Curr Opin Microbiol 9:218–228
Römling U, Balsalobre C (2012) Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 272:541–561
Rossi E, Cimdins A, Lüthje P et al (2017) “It’s a gut feeling” – Escherichia coli biofilm formation in the gastrointestinal tract environment. Crit Rev Microbiol 9:1–30
Rothenbacher FP, Suzuki M, Hurley JM et al (2012) Clostridium difficile MazF toxin exhibits selective, not global, mRNA cleavage. J Bacteriol 194:3464–3474
Roy R, Tiwari M, Donelli G et al (2017) Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. https://doi.org/10.1080/21505594.2017.1313372
Sculean A, Aoki A, Romanos G et al (2015) Is photodynamic therapy an effective treatment for periodontal and peri-implant infections? Dent Clin N Am 59:831–858
Sebaihia M, Wren BW, Mullany P et al (2006) The multidrug resistant pathogen Clostridium difficile has a highly mobile mosaic genome. Nat Genet 38:779–786
Semenyuk EG, Laning ML, Foley J et al (2014) Spore formation and toxin production in Clostridium difficile biofilms. PLoS One 9:e87757
Semenyuk EG, Poroyko VA, Johnston PF et al (2015) Analysis of bacterial communities during Clostridium difficile infection in the mouse. Infect Immun 83:4383–4391
Sengupta C, Mukherjee O, Chowdhury R (2016) Adherence to intestinal cells promotes biofilm formation in Vibrio cholerae. J Infect Dis 214:1571–1578
Shah D, Zhang Z, Khodursky A et al (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6:53
Silva JO, Martins Reis AC, Quesada-Gómez C et al (2014) In vitro effect of antibiotics on biofilm formation by Bacteroides fragilis group strains isolated from intestinal microbiota of dogs and their antimicrobial susceptibility. Anaerobe 28:24–28
Slater, Unnkrishnan M (2015) Characterisation of LuxS dependent biofilm formation by Clostridium difficile. In: 5th international Clostridium difficile symposium, p P76
Soavelomandroso AP, Bouttier S, Hoys S, Candela T, Janoir C (2015). Spatial organization of tissue-associated bacteria in a Clostridium difficile monoxenic mouse model.P95, 5th International Clostridium difficile Symposium. Bled, Slovenia
Soutourina O (2017) RNA-based control mechanisms of Clostridium difficile. Curr Opin Microbiol 36:62–68
Soutourina OA, Monot M, Boudry P et al (2013) Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet 9:e1003493
Spencer J, Leuzzi R, Buckley A et al (2014) Vaccination against Clostridium difficile using toxin fragments: observations and analysis in animal models. Gut Microbes 5:23–22
Spigaglia P (2016) Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection. Ther Adv Infect Dis 3:23–42
Spigaglia P, Barketi-Klai A, Collignon A et al (2013) Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization. J Med Microbiol 62:1386–1393
Stabler RA, He M, Dawson L et al (2009) Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10(9):R102
Stevenson E, Minton NP, Kuehne SA (2015) The role of flagella in Clostridium difficile pathogenicity. Trends Microbiol 23:1–8
Sudarsan N, Lee ER, Weinberg Z et al (2008) Riboswitches in eubacteria sense the second messenger cyclic di-GMP. Science 321:411–413
Swidsinski A, Mendling W, Loening-Baucke V et al (2008) An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198(97):e1–e6
Swidsinski A, Loening-Baucke V, Mendling W et al (2014) Infection through structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol 29:567–587
Tischler AD, Camilli A (2005) Cyclicdiguanylate regulates Vibrio cholera virulence gene expression. Infect Immun 73:5873–5882
Trejo FM, Pérez PF, De Antoni GL (2010) Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro. Antonie Van Leeuwenhoek 98:19–29
Twine SM, Reid CW, Aubry A et al (2009) Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol 191:7050–7062
Tyerman JG, Ponciano JM, Joyce P et al (2013) The evolution of antibiotic susceptibility and resistance during the formation of Escherichia coli biofilms in the absence of antibiotics. BMC Evol Biol 13:22
Valiente E, Bouché L, Hitchen P et al (2016) Role of glycosyltransferases modifying type B flagellin of emerging hypervirulent Clostridium difficile lineages and their impact on motility and biofilm formation. J Biol Chem 291:25450–25461
van Leeuwen PT, van der Peet JM, Bikker FJ et al (2016) Interspecies Interactions between Clostridium difficile and Candida albicans. mSphere 1:e00187–e00116
Varga JJ, Nguyen V, O'Brien DK et al (2006) Type IV pili-dependent gliding motility in the Gram-positive pathogen Clostridium perfringens and other Clostridia. Mol Microbiol 62:680–694
Varga JJ, Therit B, Melville SB (2008) Type IV pili and the CcpA protein are needed for maximal biofilm formation by the gram-positive anaerobic pathogen Clostridium perfringens. Infect Immun 76:4944–4951
Vlamakis H, Aguilar C, Losick R et al (2008) Control of cell fate by the formation of an architecturally complex bacterial community. Genes Dev 22:945–953
Vlamakis H, Chai Y, Beauregard P et al (2013) Sticking together: building a biofilm the Bacillus subtilis way. Nat Rev Microbiol 11:157–168
Vuotto C, Moura I, Barbanti F et al (2016) Sub-inhibitory concentrations of metronidazole increase biofilm formation in Clostridium difficile strains. Pathog Dis 74:ftv114
Walter BM, Rupnik M, Hodnik V et al (2014) The LexA regulated genes of the Clostridium difficile. BMC Microbiol 14:88
Walter BM, Cartman ST, Minton NP et al (2015) The SOS response master regulator LexA is associated with sporulation, motility and biofilm formation in Clostridium difficile. PLoS One 10:1–17
Wen Y, Behiels E, Devreese B (2014) Toxin-Antitoxin systems: their role in persistence, biofilm formation, and pathogenicity. Pathog Dis 70:240–249
Willing SE, Candela T, Shaw HA et al (2015) Clostridium difficile surface proteins are anchored to the cell wall using CWB2 motifs that recognise the anionic polymer PSII. Mol Microbiol 96:596–608
Winkler WC, Breaker RR (2005) Regulation of bacterial gene expression by riboswitches. Ann Rev Microbiol 59:487–517
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Vuotto, C., Donelli, G., Buckley, A., Chilton, C. (2018). Clostridium difficile Biofilm. In: Mastrantonio, P., Rupnik, M. (eds) Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology(), vol 1050. Springer, Cham. https://doi.org/10.1007/978-3-319-72799-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-72799-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72798-1
Online ISBN: 978-3-319-72799-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)